However, whether the levels of MLLT11 expression could correlate with transformation of the lesion from benign (low MLLT11) to a malignant (high MLLT11) phenotype, particularly in endometriosis-associated ovarian cancer, needs further investigation. The gene discussed is MLLT11; the disease is ovarian carcinoma.